Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Susanne Jung, Jochen Greiner, Stephanie von Harsdorf, Pavle Popovic, Roland Moll, Jens Schittenhelm, Kosmas Kandilaris, Volker Daniel, Alexander Kunz, Michael Schmitt, Peter Dreger

Blood Adv (2021) 5 (19): 3789–3793.

https://doi.org/10.1182/bloodadvances.2021004889

Published: 2021

Includes: Supplemental data

Journal Articles

Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL– negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.

Blood Adv (2021) 5 (11): 2518.

https://doi.org/10.1182/bloodadvances.2021005068

Published: 2021

Journal Articles

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Christine S. Higham, Griffin Collins, Kristin A. Shimano, Alexis Melton, Sandhya Kharbanda, Lena E. Winestone, James N. Huang, Jasmeen Dara, Janel R. Long-Boyle, Christopher C. Dvorak

Blood Adv (2021) 5 (8): 2106–2114.

https://doi.org/10.1182/bloodadvances.2020003988

Published: 2021

Includes: Supplemental data

Journal Articles

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation

Emily Baumrin, Natalie E. Izaguirre, Bruce Bausk, Monica M. Feeley, Camden P. Bay, Qiheng Yang, Vincent T. Ho, Lindsey R. Baden, Nicolas C. Issa

Blood Adv (2021) 5 (6): 1585–1593.

https://doi.org/10.1182/bloodadvances.2020003749

Published: 2021

Includes: Supplemental data

Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf

Blood Adv (2021) 5 (5): 1352–1359.

https://doi.org/10.1182/bloodadvances.2020003937

Published: 2021

Includes: Supplemental data

Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Blood Adv (2021) 5 (5): 1199–1208.

https://doi.org/10.1182/bloodadvances.2020003739

Published: 2021

Includes: Supplemental data

Journal Articles

Low 5-year health care burden after umbilical cord blood transplantation

Jesus Garcia Garcia, Sonya Grillo, Qing Cao, Claudio G. Brunstein, Mukta Arora, Margaret L. MacMillan, John E. Wagner, Daniel J. Weisdorf, Shernan G. Holtan

Blood Adv (2021) 5 (3): 853–860.

https://doi.org/10.1182/bloodadvances.2020003369

Published: 2021

Journal Articles

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Vikas Gupta, James A. Kennedy, Jose-Mario Capo-Chichi, Soyoung Kim, Zhen-Huan Hu, Edwin P. Alyea, Uday R. Popat, Ronald M. Sobecks, Bart L. Scott, Aaron T. Gerds, Rachel B. Salit, H. Joachim Deeg, Ryotara Nakamura, Wael Saber

Blood Adv (2020) 4 (21): 5562–5573.

https://doi.org/10.1182/bloodadvances.2020002727

Published: 2020

Includes: Supplemental data

Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley

Blood Adv (2020) 4 (19): 4980.

https://doi.org/10.1182/bloodadvances.2020001888

Published: 2020

Includes: Supplemental data

Journal Articles

Thioridazine requires calcium influx to induce MLL-AF6 –rearranged AML cell death

Claudia Tregnago, Ambra Da Ros, Elena Porcù, Maddalena Benetton, Manuela Simonato, Luca Simula, Giulia Borella, Katia Polato, Sonia Minuzzo, Giulia Borile, Paola Cogo, Silvia Campello, Alessandro Massi, Romeo Romagnoli, Barbara Buldini, Franco Locatelli, Martina Pigazzi

Blood Adv (2020) 4 (18): 4417–4429.

https://doi.org/10.1182/bloodadvances.2020002001

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Blood Adv (2020) 4 (16): 3977–3989.

https://doi.org/10.1182/bloodadvances.2020001956

Published: 2020

Journal Articles

Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation

Juliane Grimm, Madlen Jentzsch, Marius Bill, Karoline Goldmann, Julia Schulz, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind

Blood Adv (2020) 4 (16): 3864–3874.

https://doi.org/10.1182/bloodadvances.2020001904

Published: 2020

Includes: Supplemental data

Journal Articles

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Blood Adv (2020) 4 (13): 3169–3179.

https://doi.org/10.1182/bloodadvances.2020002007

Published: 2020

Includes: Supplemental data

Journal Articles

Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation

Roni Shouval, Adi Eshel, Bar Dubovski, Amir A. Kuperman, Ivetta Danylesko, Joshua A. Fein, Shalev Fried, Mika Geva, Elizaveta Kouniavski, Hadar Neuman, Ayelet Armon-Omer, Radi Shahien, Efrat Muller, Cecilia Noecker, Elhanan Borenstein, Yoram Louzoun, Arnon Nagler, Omry Koren

Blood Adv (2020) 4 (13): 2912–2917.

https://doi.org/10.1182/bloodadvances.2020001827

Published: 2020

Includes: Supplemental data

Journal Articles

Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort

Michelle Schoettler, Leslie E. Lehmann, Steven Margossian, Maia Lee, Leslie S. Kean, Pei-Chi Kao, Clement Ma, Christine N. Duncan

Blood Adv (2020) 4 (11): 2536–2547.

https://doi.org/10.1182/bloodadvances.2019001242

Published: 2020

Includes: Supplemental data

Journal Articles

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio

Blood Adv (2020) 4 (11): 2387–2391.

https://doi.org/10.1182/bloodadvances.2019000664

Published: 2020

Journal Articles

Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity

Mathilde Payen, Ioannis Nicolis, Marie Robin, David Michonneau, Johanne Delannoye, Camille Mayeur, Nathalie Kapel, Béatrice Berçot, Marie-José Butel, Jérôme Le Goff, Gérard Socié, Clotilde Rousseau

Blood Adv (2020) 4 (9): 1824–1832.

https://doi.org/10.1182/bloodadvances.2020001531

Published: 2020

Includes: Supplemental data

Journal Articles

Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia

Edward Abadir, Pablo A. Silveira, Robin E. Gasiorowski, Murari Ramesh, Adelina Romano, Ahmed H. Mekkawy, Tsun-Ho Lo, Karieshma Kabani, Sarah Sutherland, Geoffrey A. Pietersz, P. Joy Ho, Christian E. Bryant, Stephen R. Larsen, Georgina J. Clark

Blood Adv (2020) 4 (7): 1206–1216.

https://doi.org/10.1182/bloodadvances.2019001289

Published: 2020

Includes: Supplemental data

Journal Articles

Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation

Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura

Blood Adv (2020) 4 (4): 667–671.

https://doi.org/10.1182/bloodadvances.2019000343

Published: 2020

Includes: Supplemental data

Journal Articles

Presentation of BK polyomavirus–associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation

Hannah Imlay, Hu Xie, Wendy M. Leisenring, Elizabeth R. Duke, Louise E. Kimball, Meei-Li Huang, Steven A. Pergam, Joshua A. Hill, Keith R. Jerome, Filippo Milano, W. Garrett Nichols, Phillip S. Pang, Hans H. Hirsch, Ajit P. Limaye, Michael Boeckh

Blood Adv (2020) 4 (4): 617–628.

https://doi.org/10.1182/bloodadvances.2019000802

Published: 2020

Includes: Supplemental data

NARROW

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL– negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Low 5-year health care burden after umbilical cord blood transplantation

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Naive T-cell depletion in stem cell transplantation

Thioridazine requires calcium influx to induce MLL-AF6 –rearranged AML cell death

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation

Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity

Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia

Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation

Presentation of BK polyomavirus–associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only